These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10440213)

  • 41. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential.
    Schimmer AD; Hedley DW; Pham NA; Chow S; Minden MD
    Leuk Lymphoma; 2001 Jul; 42(3):429-43. PubMed ID: 11699408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide.
    Wernyj RP; Mattson MP; Christakos S
    Brain Res Mol Brain Res; 1999 Jan; 64(1):69-79. PubMed ID: 9889325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and role of Bcl-xL in human hepatocellular carcinomas.
    Takehara T; Liu X; Fujimoto J; Friedman SL; Takahashi H
    Hepatology; 2001 Jul; 34(1):55-61. PubMed ID: 11431734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
    Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
    Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
    Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis.
    El-Assaad W; El-Sabban M; Awaraji C; Abboushi N; Dbaibo GS
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):735-41. PubMed ID: 9841888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1.
    Yamamoto M; Ogawa K; Morita M; Fukuda K; Komatsu Y
    Hepatology; 1996 Mar; 23(3):552-9. PubMed ID: 8617437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA interference by expression of short hairpin RNAs suppresses bcl-xL gene expression in nasopharyngeal carcinoma cells.
    Liu F; He CW; Zhang YF; Zhou KY
    Acta Pharmacol Sin; 2005 Feb; 26(2):228-34. PubMed ID: 15663904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
    España L; Fernández Y; Rubio N; Torregrosa A; Blanco J; Sierra A
    Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of LPS-induced cytokines by Bcl-xL in a murine macrophage cell line.
    Lakics V; Medvedev AE; Okada S; Vogel SN
    J Immunol; 2000 Sep; 165(5):2729-37. PubMed ID: 10946304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes.
    Herrera B; Alvarez AM; Sánchez A; Fernández M; Roncero C; Benito M; Fabregat I
    FASEB J; 2001 Mar; 15(3):741-51. PubMed ID: 11259392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
    Lin J; Page C; Jin X; Sethi AO; Patel R; Nunez G
    Anticancer Res; 2001; 21(2A):831-9. PubMed ID: 11396172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-human hepatocellular carcinoma effects of tumor necrosis factor-related apoptosis-inducing ligand in vitro & in vivo.
    Guo BC; Xu YH
    Acta Pharmacol Sin; 2001 Sep; 22(9):831-6. PubMed ID: 11749866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
    Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
    Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
    Luo D; Cheng SC; Xie H; Xie Y
    Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.
    Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G
    Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity.
    Buchmann A; Willy C; Buenemann CL; Stroh C; Schmiechen A; Schwarz M
    Cell Death Differ; 1999 Feb; 6(2):190-200. PubMed ID: 10200566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.